Seoul, South Korea

Dong-yeol Lee

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Primoris Therapeutics Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong-yeol Lee. Retrieved from https://idiyas.com/inventor/dong-yeol-lee-8zshmkee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dong-yeol Lee and Cord Blood Stem Cell Research.

Introduction

Dong-yeol Lee is an inventor based in Seoul, South Korea. His patent work concerns the isolation and cultivation of cord blood stem cells expressing high levels of GDF-3.

Latest Patents

Lee is associated with 1 patent: “Method for Isolating and Culturing Cord Blood Stem Cells Expressing GDF-3 at High Level, and Use of GDF-3.” The invention focuses on methods for isolating and culturing these cells and their potential uses.

Career Highlights

Lee is associated with Primoris Therapeutics Co., Ltd. His listed patent reflects work in stem cell research and biotechnology.

Collaborations

Lee’s listed coworkers include Jae-yong Lee and Hee-Jin Ahn.

Conclusion

Dong-yeol Lee’s patent activity centers on cord blood stem cells and GDF-3, connecting his work with biotechnology research at Primoris Therapeutics Co., Ltd.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…